+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celyad - logo

Celyad SA, a clinical-stage biopharmaceutical company, focuses on engineered cell therapy treatments. It develops therapeutic therapies for the treatment of unmet medical needs in cardiology and oncology. The company's best known product is the C-Cure, an autologous cell therapy for the treatment of heart failure. The company was formerly known as Cardio3 BioSciences SA and changed its name to Celyad SA in May 2015. Celyad SA was founded in 2004 and is based in Mont-Saint-Guibert, Belgium.

CAR T-cell Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

CAR T-cell Therapy - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Global Cell Therapy Market 2023-2027 - Product Thumbnail Image

Global Cell Therapy Market 2023-2027

  • Report
  • August 2023
  • 159 Pages
  • Global
From
Myelodysplastic Syndrome - Pipeline Review, H1 2020 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1667 Pages
  • Global
From
From
From
CAR-T Therapies Market (2nd Edition), 2019-2030 - Product Thumbnail Image

CAR-T Therapies Market (2nd Edition), 2019-2030

  • Report
  • August 2019
  • 580 Pages
  • Global
From
From
Tumor Infiltrating Lymphocytes Global Market Report 2024 - Product Thumbnail Image

Tumor Infiltrating Lymphocytes Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
CAR-T Therapy Global Market Report 2024 - Product Thumbnail Image

CAR-T Therapy Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Immuno-Oncology Drugs Global Market Report 2024 - Product Thumbnail Image

Immuno-Oncology Drugs Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
CAR T - Pipeline Insight, 2024 - Product Thumbnail Image

CAR T - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
The Global Market for Stem Cells - Product Thumbnail Image

The Global Market for Stem Cells

  • Report
  • March 2018
  • 162 Pages
  • Global
From
Loading Indicator